Prescription Drug Pricing: The Fine Line Between Value and Greed

Stewart Lyman

Value. It’s one of the most frequently used buzzwords on both Wall Street and in healthcare. Virtually every press release from a publicly traded company assures us that (Read more...)

SBIR Award, $1M Investment Get ONL Therapeutics to Clinical Trials

ONL_Logo_FNL_LG Sarah Schmid

ONL Therapeutics, a University of Michigan spin-out biopharmaceutical startup working on sight-preserving therapies for retinal diseases, announced today that it has won a $1.3 million Small (Read more...)